Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human FOLH1 Stable Cell Line

    [CAT#: S01YF-1023-PY270]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Other Targets
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;LNCap
    Target Classification
    Other Targets Drug Discovery Assays and Products
    Target Research Area
    Metabolic Research
    Related Diseases
    Hyperhomocysteinemia; Prostate Cancer
    Gene ID
    Human:2346
    UniProt ID
    Human:Q04609

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    FOLH1, also known as prostate-specific membrane antigen (PSMA), has various applications in different fields. In cancer research, FOLH1 has been used as a target for imaging agents in prostate-specific membrane antigen inhibitor studies. It has also been studied in relation to genetic polymorphisms and arsenic methylation efficiency during pregnancy. Additionally, FOLH1 has been compared to other imaging techniques, such as 18F-FDG PET/CT, in evaluating patients with upper tract urothelial carcinoma. Furthermore, FOLH1 expression has been examined in the neovasculature of high-grade gliomas, suggesting its potential role in tumor angiogenesis. Finally, scRNA-seq analysis has revealed the heterogeneity of the tumor microenvironment related to lymph node metastasis in prostate cancer, with FOLH1 being identified as a marker in luminal cell subgroups. These findings highlight the diverse applications and significance of FOLH1 in different research areas.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human FOLH1 Stable Cell Line (S01YF-1023-PY270). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Skyler Johnson (Verified Customer)

    How is FOLH1/PSMA regulated in prostate cancer? Mar 20 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    FOLH1 is regulated by epigenetic control and may be altered in progression or with androgen deprivation therapy, suggesting a complex regulatory mechanism in prostate cancer. Mar 20 2021

    chat Alex Garcia (Verified Customer)

    Can FOLH1 expression be used for diagnostic imaging in cancers? Jun 18 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    FOLH1 (PSMA) expression in hepatocellular carcinoma and other tumor types suggests its potential use for prognosis and diagnostic imaging. Jun 18 2022

    Published Data

    Fig.1 The attenuation of LNCaP cell proliferation was observed following the knockdown of PSMA.

    Cell viability was assessed through the utilization of the CCK-8 assay, with absorbance at 450 nm being employed to measure the protracted cell growth curve. Within the normal medium, it was observed that the interference group exhibited a lower proliferative capacity compared to both the blank group and the non-interference group, with the maximum inhibition rate being reached at the 120-hour mark. In the medium containing LY2**002, cells were found to possess proliferative capacities at diminished levels. The data presented here represent the mean ± SD of a representative experiment conducted in triplicate (n=3).

    Ref: Guo, Zhenghui, et al. "Prostate specific membrane antigen knockdown impairs the tumorigenicity of LNCaP prostate cancer cells by inhibiting the phosphatidylinositol 3-kinase/Akt signaling pathway." Chinese Medical Journal 127.5 (2014): 929-936.

    Pubmed: 24571890

    DOI: NA

    Research Highlights

    Hatamabadi, Dara. et al. "Synthesis and Radiolabeling of Glu-Urea-Lys with 99mTc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor." Cancer biotherapy & radiopharmaceuticals, 2023.
    This article investigates the impact of climate change on global agriculture and food security. It begins by outlining prevalent difficulties encountered by small-scale farmers, especially in developing nations, such as droughts, floods, and soil deterioration. The abstract subsequently examines potential adaptation methods, including the utilization of climate-resistant crop varieties and advanced water management techniques. Lastly, it emphasizes the significance of international collaboration and investment in sustainable agriculture to mitigate the consequences of climate change and ensure food security for the entire population.
    Hatamabadi, Dara. et al. "Synthesis and Radiolabeling of Glu-Urea-Lys with 99mTc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor." Cancer biotherapy & radiopharmaceuticals, 2023.
    Pubmed: 37578479   DOI: 10.1089/cbr.2023.0024

    Soler-Blasco, Raquel. et al. "Influence of genetic polymorphisms on arsenic methylation efficiency during pregnancy: Evidence from a Spanish birth cohort." The Science of the total environment, 2023.
    Inorganic arsenic (iAs) is a commonly found toxic metalloid with known effects on human health. The metabolism and toxicity of iAs are influenced by variations in genes such as AS3MT and GSTO2. Despite this, there is a lack of research on the impact of genetic polymorphisms during pregnancy. The objective of this study was to investigate the relationship between AS3MT, GSTO2, N6AMT1, MTHFR, MTR, FTCD, CBS, and FOLH1 polymorphisms and iAs methylation efficiency in pregnant women.
    Soler-Blasco, Raquel. et al. "Influence of genetic polymorphisms on arsenic methylation efficiency during pregnancy: Evidence from a Spanish birth cohort." The Science of the total environment, 2023.
    Pubmed: 37495132   DOI: 10.1016/j.scitotenv.2023.165740

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare